Scott Fishman

About

Scott Fishman has over 30 years’ experience in healthcare marketing research and commercial analysis. As CEO of the firm he started in 1989, Scott directed the evolution of Research by Design (RBD) from a bedroom startup to one of the most successful and prominent firms in the healthcare research industry. Under Scott’s guidance, RBD became a key consulting resource for virtually every major pharmaceutical company, as well as a wide range of biotechnology and medical device manufacturers and healthcare advertising agencies. Following the sale of his firm to a global holding company in 2006, Scott founded Ethos LifeScience Advisors. Ethos provides guidance for investors, entrepreneurs, and start up enterprises, informing investment decisions with definitive analysis of the clinical and commercial value of new technologies. Scott also co-developed, launched and serves as consulting Program Executive for the Commercialization Acceleration Program (CAP) at the Wharton Small Business Develo

Investment Focus

Location

Philadelphia, US